Current Pharmaceutical Design

Editorial [Hot Topic: Acute Hepatitis C: Epidemiology, Pathogenesis and Therapy (Executive Editor: Paolo Fabris) ]
pp. 1644-1645(2)
Author: Fabris, Paolo

Epidemiology of HCV Infection
pp. 1646-1654(9)
Authors: Baldo, V.; Baldovin, T.; Trivello, R.; Floreani, A.

HCV Screening to Enable Early Treatment of Hepatitis C: A athematical Model to Analyse Costs and Outcomes in Two Populations
pp. 1655-1660(6)
Authors: Tramarin, A.; Gennaro, N.; Compostella, F. A.; Gallo, C.; Wendelaar Bonga, L. J.; Postma, M. J.

Acute Hepatitis C: Clinical Aspects, Diagnosis, and Outcome of Acute HCV Infection
pp. 1661-1665(5)
Authors: Fabris, P.; Fleming, V. M.; Giordani, M. T.; Barnes, E.

Cellular Immunity and Acute Hepatitis C Infection
pp. 1666-1677(12)
Authors: Fitzmaurice, K.; Klenerman, P.

HCV and Autoimmunity
pp. 1678-1685(8)
Authors: Ferri, S.; Muratori, L.; Lenzi, M.; Granito, A.; Bianchi, F. B.; Vergani, D.

Therapy of Acute Hepatitis C: A Review of Literature
pp. 1686-1689(4)
Authors: Santantonio, T.; Fasano, M.

Acute HCV in HIV-Positive Individuals - A Review
pp. 1690-1697(8)
Authors: Danta, M.; Dusheiko, G. M.

Ligands and Therapeutic Perspectives of Adenosine A2A Receptors
pp. 1698-1722(25)
Authors: Diniz, C.; Borges, F.; Santana, L.; Uriarte, E.; Oliveira, J. M.A.; Goncalves, J.; Fresco, P.

Clinical Drugs that Interact with St. John's Wort and mplication in Drug Development
pp. 1723-1742(20)
Authors: Di, Yuan M.; Li, Chun G.u.a.n.g.; Xue, Charlie C.h.a.n.g.l.i.; Zhou, Shu-Feng